4th Quarter - Report

FEROX STRATEGIES for VIATRIS INC

Firm
Client
Income
$70,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Policy and oversight related to the generic pharmaceutical industry; Issues related to drug pricing; Issues related to FDA generic drug approval process. General issues related to Agriculture Appropriations.

LobbyistCovered position, as disclosed
CRISTINA ANTELO —
DEBRA DIXON —
MICHAEL TAGGART —
MARK WILLIAMS —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.